1. Home
  2. PGEN vs BANC Comparison

PGEN vs BANC Comparison

Compare PGEN & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.21

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Banc of California Inc.

BANC

Banc of California Inc.

N/A

Current Price

$16.24

Market Cap

2.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PGEN
BANC
Founded
1998
1941
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2013
2002

Fundamental Metrics

Financial Performance
Metric
PGEN
BANC
Price
$4.21
$16.24
Analyst Decision
Buy
Buy
Analyst Count
4
12
Target Price
$13.67
★ $21.75
AVG Volume (30 Days)
★ 6.8M
2.0M
Earning Date
11-04-2026
10-27-2026
Dividend Yield
N/A
★ 2.89%
EPS Growth
N/A
★ N/A
EPS
★ 0.12
N/A
Revenue
$230,981,000.00
★ $1,818,792,000.00
Revenue This Year
$2,380.31
$3.86
Revenue Next Year
$84.01
$11.82
P/E Ratio
$34.63
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.04
$16.35
52 Week High
$8.98
$21.93

Technical Indicators

Market Signals
Indicator
PGEN
BANC
Relative Strength Index (RSI) 31.74 26.76
Support Level $3.89 N/A
Resistance Level $4.41 $19.26
Average True Range (ATR) 0.36 0.51
MACD -0.01 -0.20
Stochastic Oscillator 16.78 0.99

Price Performance

Historical Comparison
PGEN
BANC

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About BANC Banc of California Inc.

Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.

Share on Social Networks: